LATEX CONDOM LOT UNIFORMITY NEEDS FURTHER STUDY
This article was originally published in The Tan Sheet
Executive Summary
LATEX CONDOM LOT UNIFORMITY NEEDS FURTHER STUDY, according to a recent FDA-sponsored investigation conducted principally by Program for Appropriate Technology in Health (PATH) of Seattle. Noting that results of a retrospective study of condoms already in distribution "were too variable to reach conclusions about condom deterioration trends over time," the report recommends additional studies "to determine if non-uniform lots of condoms are common in the marketplace, if lack of uniformity affects aging, and what parameters could best be used to control uniformity through standards and specifications."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning